glp-1/gip dual agonist Tirzepatide's Unique Mechanism of Action GLP-1/GIP Dual Receptor Agonist -

and preterm delivery (RR = 1.34

With companies like Yara making these treatments more accessible through generic options, we're entering a new era where sustainable weight loss and improved metabolic health are within reach for millions of people

Exploring the impact of sodium-glucose cotransporter-2 inhibitors on genitourinary toxicities in prostate cancer patients undergoing radiation therapy: a case study and discussion

Currently, histologic improvement remains the primary criterion for evaluating effective outcomes in MASLD, but invasive tests are often not accepted in the pediatric population

Bistola V, et al

Exploring SGLT2 Inhibitors SGLT2 inhibitors, including empagliflozin (Jardiance), dapagliflozin (Farxiga), and canagliflozin (Invokana), offer a different therapeutic pathway